Teratogenic drugs ??? part 1
- 1 April 2002
- journal article
- Published by Wolters Kluwer Health in Adverse Drug Reaction Bulletin
- Vol. &NA; (213) , 815-818
- https://doi.org/10.1097/00012995-200204000-00001
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Losartan and fetal toxic effectsThe Lancet, 2001
- Early Medical Abortion With Methotrexate and MisoprostolObstetrics & Gynecology, 2001
- DIAGNOSING THE FULL SPECTRUM OF FETAL ALCOHOL-EXPOSED INDIVIDUALS: INTRODUCING THE 4-DIGIT DIAGNOSTIC CODEAlcohol and Alcoholism, 2000
- Epidemiological assessment of misoprostol teratogenicityBJOG: An International Journal of Obstetrics and Gynaecology, 2000
- The effects of methotrexate on pregnancy, fertility and lactationQJM: An International Journal of Medicine, 1999
- Malformations in Offspring of Women with Epilepsy: A Prospective StudyEpilepsia, 1999
- Principles of teratogenicityCurrent Obstetrics & Gynaecology, 1999
- An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal developmentMolecular and Cellular Biochemistry, 1997
- An assessment of lithium using the iehr evaluative process for assessing human developmental and reproductive toxicity of agentsReproductive Toxicology, 1995
- Fetal intraventricular haemorrhage and maternal warfarinThe Lancet, 1993